The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

The Journal of Immunology, 2007, 179, 3214 -3221
Copyright © 2007 by The American Association of Immunologists, Inc.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reading, P. C.
Right arrow Articles by Brooks, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reading, P. C.
Right arrow Articles by Brooks, A. G.

IL-18, but not IL-12, Regulates NK Cell Activity following Intranasal Herpes Simplex Virus Type 1 Infection1

Patrick C. Reading2, Paul G. Whitney, Daniel P. Barr, Magdalena Wojtasiak, Justine D. Mintern, Jason Waithman and Andrew G. Brooks

Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Infection of the respiratory tract with HSV type 1 (HSV-1) can have severe clinical complications, yet little is known of the immune mechanisms that control the replication and spread of HSV-1 in this site. The present study investigated the protective role of IL-12 and IL-18 in host defense against intranasal HSV-1 infection. Both IL-12 and IL-18 were detected in lung fluids following intranasal infection of C57BL/6 (B6) mice. IL-18-deficient (B6.IL-18–/–) mice were more susceptible to HSV-1 infection than wild-type B6 mice as evidenced by exacerbated weight loss and enhanced virus growth in the lung. IL-12-deficient (B6.IL-12–/–) mice behaved similarly to B6 controls. Enhanced susceptibility of B6.IL-18–/– mice to HSV-1 infection correlated with a profound impairment in the ability of NK cells recovered from the lungs to produce IFN-{gamma} or to mediate cytotoxic activity ex vivo. The weak cytotoxic capacity of NK cells from the lungs of B6.IL-18–/– mice correlated with reduced expression of the cytolytic effector molecule granzyme B. Moreover, depletion of NK cells from B6 or B6.IL-12–/– mice led to enhanced viral growth in lungs by day 3 postinfection; however, this treatment had no effect on viral titers in lungs of B6.IL-18–/– mice. Together these studies demonstrate that IL-18, but not IL-12, plays a key role in the rapid activation of NK cells and therefore in control of early HSV-1 replication in the lung.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Herpes simplex virus type 1 (HSV-1)3 is a large dsDNA virus that infects epidermal or epithelial cells before establishment of latent infection in sensory neurons. Reactivation of the virus can cause disease in immunocompetent and immunodeficient individuals, resulting in a variety of illnesses, including disseminated infection, encephalitis, and pneumonia. HSV-1 infection elicits a multifaceted antiviral response to control the virus, requiring elements of both the innate and adaptive immune systems.

NK cells restrict early virus spread by direct lysis of virus-infected cells and through secretion of antiviral cytokines such as IFN-{gamma} and TNF-{alpha}. Severe herpesvirus infections have been reported in human patients with NK cell deficiencies (1, 2), and NK cell depletion was associated with exacerbated virus replication and disease in some (3, 4, 5, 6, 7), but not all (8, 9, 10), murine models of HSV-1 infection. Because activated T cells can express NK cell markers (11), caution must be extended in the interpretation of NK depletion studies using anti-asialo-GM1 (AAGM) and anti-NK1.1 Abs due to their potential to affect T cell responses.

Both CD4 and CD8 T cells have been implicated in limiting the severity of HSV-1 infections. Clear roles for CD4 and CD8 T cells have been described in the resolution of HSV-1 in murine models of infection (12, 13, 14, 15), although the mechanisms by which each population can mediate protection have not been fully elucidated. CD4 T cells are classically thought of as "helper" cells, inducing CD8 T cell (CTL) responses through licensing of dendritic cells and class-switching of B cells through the secretion of cytokines. Activated CTLs produce antiviral and proinflammatory cytokines and are potent killers of virus-infected cells.

NK and T cell functions are subject to regulation by a number of cytokines, including IL-12 and IL-18. Both IL-12 and IL-18 induce production of IFN-{gamma} and other cytokines by NK and T cells, and stimulate NK cell activation and T cell proliferation (16, 17, 18). Furthermore, IL-12 and IL-18 have a synergistic effect on IFN-{gamma} production (18, 19, 20). While IL-12 and IL-18 share some biological activities, there is no significant homology is noted between the two cytokines at the protein level. IL-12 is produced by activated macrophages and dendritic cells as a covalently linked heterodimer (p70) composed of two chains, p40 and p35 (reviewed in Ref. 21). IL-12p40 is often secreted in excess over the p70 heterodimer and can form p80 homodimers that antagonize IL-12 activity (22). IL-18 is produced largely by activated macrophages, dendritic cells, and epithelial cells and is synthesized as a precursor protein (pro-IL-18, 24 kDa), which requires cleavage by IL-1β-converting enzyme to generate the bioactive 18-kDa protein (23).

We hypothesized that if IL-12 and/or IL-18 modulate NK and T cell function, the absence of either might alter disease pathogenesis following HSV-1 infection. We have used a murine intranasal model to examine the responses of mice deficient in either IL-12p40 (B6.IL-12–/–) or IL-18 (B6.IL-18–/–) to HSV-1 infection. Few studies have examined the pathogenesis of HSV-1 in the respiratory tract, despite reports that HSV-1 infection of neonates and immunocompromised patients is associated with a range of pathologic conditions, including pneumonia and meningoencephalitis (24, 25, 26). The results reported in this study indicate that IL-18-deficient mice are more susceptible to HSV-1 infection of the lung and that IL-18, but not IL-12, plays an important role in early NK cell activation after HSV-1 infection. Of interest, the absence of either IL-12 or IL-18 had no appreciable effects on adaptive responses in the lung. Together, these studies highlight the importance of the innate response, and in particular NK cells, in limiting acute HSV-1 infection of the lung.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Mice, viruses, and peptide

C57BL/6 (B6) mice, and mice with a deletion of the gene encoding the p40 subunit of IL-12 (B6.IL-12–/–) (27) or IL-18 (B6.IL-18–/–) (28) were housed in specific pathogen-free conditions in the animal facility at the Department of Microbiology and Immunology, The University of Melbourne (Parkville, Victoria, Australia). Adult male mice (6- to 10-wk-old) were used in all experiments. The KOS strain of HSV-1 was propagated and titrated using Vero cells. The glycoprotein B (gB) peptide with residues 498–505 (gB498–505) with the sequence SSIEFARL was obtained from Auspep. Tetramers containing this immunodominant gB peptide (H-2Kb-gB498–505 tetramer) were prepared as described elsewhere (29).

Infection and treatments of mice

Mice were anesthetized and infected via intranasal route with 106 PFU of HSV-1 (unless otherwise stated) in 50 µl of PBS. Each day, mice were weighed individually and monitored for signs of illness. All research complied with the University of Melbourne Animal Experimentation Ethics guidelines and policies. To determine virus titers in organs, mice were euthanized, and lung, brain, liver, spleen, and trigeminal ganglia (TG) were removed, homogenized, and clarified by centrifugation. The samples were assayed for infectious virus by plaque assay on Vero cells.

Recovery of immune cells for flow cytometry and cytotoxic assays

Bronchoalveolar lavage fluid (BALF) and lung cells were obtained from mock-infected and HSV-1-infected mice at various times postinfection (p.i.). For collection of BALF cells, mice were sacrificed and the lungs were flushed three times with a 1-ml volume of PBS through a blunted 23-gauge needle inserted into the trachea. The three lavage samples were pooled and the cells treated with Tris-NH4Cl (0.14 M NH4Cl in 17 mM Tris (pH 7.2)) to lyse erythrocytes, washed twice, and resuspended in RPMI 1640 medium supplemented with 10% FBS. Single-cell suspensions of lung cells were prepared by mincing lung tissue before incubation with 2 mg/ml collagenase A (Roche Diagnostics) in serum-free RPMI 1640 at 37°C for 30 min. Lungs were then sieved through wire mesh followed by hypotonic lysis of erythrocytes.

Flow cytometric analysis of cell surface and intracellular Ags

Single-cell suspensions of BALF or lung cells were incubated on ice for 20 min with supernatant from hybridoma 2.4.G2 to block Fc receptors and then stained with the indicated Abs. All Abs were purchased from BD Biosciences. After staining, the cells were washed and propidium iodide was added before flow cytometric analysis on a FACSCalibur flow cytometer (BD Biosciences). To detect intracellular IFN-{gamma} from HSV-1-specific CD8 T cells, lung cell suspensions were stimulated with gB498–505 peptide in the presence of 10 µg/ml brefeldin A (Sigma-Aldrich) for 6 h at 37°C. In some assays lung cell suspensions were stimulated with an equivalent concentration of irrelevant peptide (SIINFEKL, OVA257–264) under similar conditions. To detect intracellular IFN-{gamma} from NK cells, BALF cells were stained with anti-mouse IFN-{gamma} as described (7). To detect intracellular granzyme B, BALF cells were stained with CD3{epsilon}-FITC and NK1.1-PE, fixed and permeabilized before staining with allophycocyanin-conjugated anti-human granzyme B (Caltag Laboratories). Cells were analyzed on a FACSCalibur flow cytometer collecting data on at least 10,000 lymphocytes.

ELISA for IFN-{gamma}, IL-12, IL-18 in BALF

Levels of IFN-{gamma} in BALF were determined by sandwich ELISA from BD Biosciences according to the manufacturer’s instructions. Levels of IL-12 and IL-18 were determined using a BD OptEIA ELISA kit for IL-12 (p70) and a mouse IL-18 ELISA kit from MBL. BALF samples were clarified at 1800 rpm for 10 min before the concentration of each cytokine was determined relative to a standard curve.

Cytotoxic assays

NK cell cytotoxicity and HSV-1-specific CTL activity in lung cell suspensions was assayed using standard 51Cr release assays. Briefly, NK cell cytotoxicity was tested using YAC-1 target cells, RMA-S cells, or RMA-S cells transfected with Rae1β (RMA-S-Rae1β) (30). EL4 cells were used as targets for HSV-1-specific CTL lysis with or without addition of 1 µM gB498–505 or OVA257–264 peptide. The percentage of specific 51Cr release was calculated as the percentage of specific lysis = (experimental release – spontaneous release)/(total detergent release – spontaneous release) x 100. The spontaneous release values were always <15% of total lysis.

Statistical analysis

Results from 3 to 10 mice in each group were expressed as mean ± SD unless otherwise stated. Differences in viral titer and cell numbers between two groups were assessed for significance by Student’s t test (two-tailed distribution, two sample equal variance). Values for p < 0.05 were considered significant.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
Increased mortality of B6.IL-18–/– mice following intranasal HSV-1 infection

We initially compared the susceptibility of B6, B6.IL-12–/– and B6.IL-18–/– mice to intranasal infection with increasing doses of HSV-1, ranging from 106 up to 5 x 107 PFU per mouse. Although neither B6 nor B6.IL-12–/– mice succumbed to infection at any dose tested, B6.IL-18–/– mice were significantly more susceptible to the infection with 70% survival (7/10) and 30% survival (3/10) recorded at doses of 107 PFU and 5 x 107 PFU, respectively (Fig. 1). All deaths were recorded by day 10, and mice displayed symptoms of pneumonia (huddling behavior, rapid breathing) before death. Surviving mice recovered rapidly and did not display respiratory or neurological abnormalities at any time up to day 30. Together, these findings are consistent with an important role for endogenous IL-18, but not IL-12, in host defense against HSV-1-induced pneumonia.


Figure 1
View larger version (21K):
[in this window]
[in a new window]

  		FIGURE 1. B6.IL-18–/– mice are more susceptible to intranasal HSV-1 infection than B6 or B6.IL-12–/– mice. Male B6, B6.IL-12–/–, and B6.IL-18–/– mice were infected via the intranasal route with increasing doses of HSV-1 strain KOS (106, 5 x 106, 107, 5 x 107 PFU per mouse). Mice were observed daily and assessed for signs of illness over a 30-day period. Results are shown for inoculum doses of 107 and 5 x 107 PFU and are expressed as the percentage of survival from groups of 10 mice each. Mice with pronounced signs of pneumonia (huddling, labored breathing, inability to take food/water) were considered moribund and were euthanised. Mice inoculated with doses of <107 PFU did not display pronounced signs of pneumonia and all mice survived the infection to day 30 (data not shown). Data are representative of two independent experiments.

 
Exacerbation of disease in B6.IL-18–/– mice following intranasal infection with HSV-1

To explore the pathogenesis of HSV-1 in the respiratory tract in more detail, we compared weight loss and signs of disease in mice infected with a nonlethal dose of HSV-1 (Fig. 2A). B6 and B6.IL-12–/– mice showed modest weight loss over the first 5–7 days of infection but recovered rapidly thereafter. B6.IL-18–/– mice lost considerably more weight and took longer to regain normal body weight. At this dose, no visible signs of pneumonia were observed in any infected animals.


Figure 2
View larger version (32K):
[in this window]
[in a new window]

  		FIGURE 2. Increased virulence of HSV-1 for B6.IL-18–/– mice. A, Groups of male B6 (square symbols), B6.IL-12–/– (triangle symbols), and B6.IL-18–/– mice (circle symbols) were mock-infected with Vero lysate (open symbols) or infected with 106 PFU of HSV-1 (closed symbols) and monitored for 16 days. Mice were weighed daily and results expressed as the mean percentage of weight loss of each group, compared with the weight immediately before infection. Data from each day are expressed as the mean ± SEM of 5–7 mice per group. B, Growth and replication of HSV-1 in the lungs of B6 ({blacksquare}), B6.IL-12–/– ({triangleup}), and B6.IL-18–/– (•) mice. At the indicated times after infection, mice infected with HSV-1 were sacrificed and the titer of infectious virus in the lungs determined by plaque assay on Vero cells. Virus titers are expressed as PFU per lung. The dashed line indicates the minimum detection limit of the plaque assay. Samples below the dashed line are regarded as <1.8 (log10 PFU per lung). *, p < 0.05; **, p < 0.01 as determined by Student’s t test to represent viral titers significantly different to those of B6 controls. Data are representative of three independent experiments.

 
Viral replication was examined in the lungs of B6, B6.IL-12–/–, and B6.IL-18–/– mice at various times after intranasal infection with 106 PFU of HSV-1 (Fig. 2B). Low viral titers were recorded 4 h p.i., which had increased 100- to 1000-fold by day 1, consistent with acute viral replication within the lung. As reported previously for B6 mice (7), maximum titers were observed 1–3 days after infection, with clearance achieved 5–7 days after infection.

At day 1 there was a tendency to recover higher virus titers from the lungs of B6.IL-18–/– animals, and this tendency was significant compared with B6 controls in two independent experiments but not in a third (p = 0.038, p = 0.023, and p = 0.058 using Student’s t test). By day 3, however, elevated lung titers in B6.IL-18–/– mice were highly significant when compared with B6 controls (p < 0.01 in three independent experiments, Student’s t test). At no time were lung virus titers from B6.IL-12–/– mice found to be different to those from B6 control mice. Plaque assay did not detect virus in homogenates of liver, kidney, or spleen prepared from B6, B6.IL-12–/–, and B6.IL-18–/– mice at 1, 3, 5, 7, or 20 days after HSV-1 infection.

HSV-1 replication can be suppressed at the primary site of infection by the host immune response, however virus can also enter sensory neurons to replicate productively and/or to establish latent infection. Plaque assay was used to determine the titers of replicating virus present in homogenates prepared from TG at days 1, 3, 5, 7, and 20 after intranasal infection with 106 PFU of HSV-1. Growth of HSV-1 was detected only at days 3 and 5 p.i. and virus titers were similar in TG homogenates prepared from B6, B6.IL-12–/–, or B6.IL-18–/– mice (data not shown). Latent infection was confirmed in TG of all animals after day 20 p.i. using RT-PCR and differences in viral DNA copy number between B6-infected mice and B6.IL-12–/–- or B6.IL-18–/–-infected mice were not significant in two independent experiments.

IL-12 and IL-18 are induced in the lung during HSV-1 infection

We next determined levels of IL-12 (p70) and IL-18 in BALF from mice at various times after intranasal infection with HSV-1. As seen in Fig. 3, levels of each cytokine peaked at day 3 p.i. and declined thereafter. As expected, IL-12 could not be detected in day 3 BALF from B6.IL-12–/– mice (Fig. 3A), nor could IL-18 be detected in BALF from B6.IL-18–/– mice (Fig. 3B). Thus, although both IL-12 and IL-18 are induced in the lung during HSV-1 infection, only deficiency in IL-18 was associated with a more severe disease phenotype.


Figure 3
View larger version (24K):
[in this window]
[in a new window]

  		FIGURE 3. Levels of IL-12 (p70) and IL-18 in BALF after intranasal infection with HSV-1. Levels of IL-12 (A) and IL-18 (B) in BALF fluids from uninfected mice (open symbols) or from mice at various times after intranasal infection with 106 PFU of HSV-1 (closed symbols) were clarified and assayed for levels of IL-12 or IL-18 as described. Data shown represent protein levels present in the BALF from B6 (squares), B6.IL-12–/– (triangles), or B6.IL-18–/– (circles) mice and are representative of three independent experiments. The detection limit of IL-12 and IL-18 ELISAs are 62.5 and 25 pg/ml, respectively, and are indicated by the dashed line. Samples below the dashed line are regarded as <62.5 pg/ml for IL-12 or <25 pg/ml for IL-18.

 
Inflammatory cell counts in BALF are increased in B6.IL-18–/– mice after HSV-1 infection

To determine the effects of IL-12 or IL-18 deficiency on lung inflammation, we characterized the immune cells recovered in the BALF from B6, B6.IL-12–/–, and B6.IL-18–/– mice after intranasal infection with 106 PFU of HSV-1. BALF cell numbers increased transiently following infection, peaking at day 7 and declining thereafter (Fig. 4A). Significantly more total BALF cells were recovered from B6.IL-18–/– mice compared with B6 mice at days 3 and 7 p.i. (p < 0.05, by Student’s t test). Differential counts confirmed our previous findings (7) that macrophages and lymphocytes were the predominant cell types recruited to the airways during HSV-1 infection; neutrophils comprised <10% of BALF cells from B6, B6.IL-12–/–, and B6.IL-18–/– at all time points tested (data not shown). Flow cytometry showed an early influx of NK cells (NK1.1+ CD3{epsilon}–, Fig. 4B) into the BALF followed by the subsequent recruitment of T cells (CD3{epsilon}+ NK1.1–) (Fig. 4C). Compared with B6 controls, no deficit was observed in the ability of B6.IL-12–/–- or B6.IL-18–/–-infected mice to recruit NK cells or T cells to the lung (Fig. 4, B and C). Rather, NK cell and T cell numbers were higher in BALF from B6.IL-18–/–-infected mice at days 3 and 7, respectively, in independent experiments. CD8+ T cells predominated over CD4+ T cells at days 7 and 10 with CD4+ to CD8+ ratios of up to 1:5 observed at day 7 p.i. (Fig. 4D). The absence of endogenous IL-12 or IL-18 had no significant effect on CD4+ to CD8+ ratios.


Figure 4
View larger version (37K):
[in this window]
[in a new window]

  		FIGURE 4. Increased cell numbers in BALF from B6.IL-18–/– mice after intranasal infection with HSV-1. B6 ({blacksquare}), B6.IL-12–/– ({square}), or B6.IL-18–/– (Figure 4) mice were infected with 106 PFU HSV-1 and at various times p.i. BALF cells were isolated, stained with fluorescent-labeled Abs, and examined by flow cytometry. A, The total number of viable cells was determined by trypan blue exclusion. B, The total number of NK cells. NK cells were identified as CD3– NK1.1+ cells in the lymphocyte gate. C, The total number of T cells. T cells were identified as CD3+ NK1.1– cells in the lymphocyte gate. D, T cells (CD3+ NK1.1–) in day 7 BALF were further characterized for expression of CD4 or CD8 surface markers. Data for individual mice are shown. Data in A–C represent the mean ± SD of cell counts for three to five mice at each time point and are representative of two or more independent experiments. *, p < 0.05 determined by Student’s t test, which represent cell numbers significantly different to those of B6 controls.

 
No differences in CD8+ T cell responses in the lung after intranasal HSV-1 infection of B6, B6.IL-12–/– and B6.IL-18–/– mice

Both IL-12 and IL-18 have been reported to play roles in augmenting T cell responses (16, 17, 18). As CD8+ T cells are the major cell type recruited to the airways following intranasal infection with HSV-1 (Fig. 4C), we assessed CD8+ T cell activation in B6, B6.IL-12–/–, or B6.IL-18–/– mice and determined 1) the proportion of CD8+ T cells that recognized the immunodominant epitope corresponding to gB498–505 using H-2Kb-gB498–505 tetramers (Fig. 5, A and B), 2) the proportion of CD8+ T cells that produced IFN-{gamma} following in vitro stimulation with peptide gB498–505 (Fig. 5C), and 3) the ability of CD8+ T cells to kill target cells pulsed with the gB498–505 peptide in vitro (Fig. 5D). In all assays, gB498–505-specific CD8+ T cells were first detected in the lung at day 5 p.i., and no significant differences were noted in the responsiveness of cells from B6, B6.IL-12–/–, or B6.IL-18–/– mice. Together, these data indicate that loss of either IL-12 or IL-18 did not significantly impair recruitment and activation of T cells in the lung following intranasal HSV-1 infection.


Figure 5
View larger version (46K):
[in this window]
[in a new window]

  		FIGURE 5. Recruitment and activation of HSV-1-specific CD8+ T cells in the lung after intranasal infection of B6, B6.IL-12–/–, and B6.IL-18–/– mice. Groups of B6 ({blacksquare}), B6.IL-12–/– ({triangleup}), or B6.IL-18–/– (•) mice were infected via the intranasal route with 106 PFU of HSV-1 and lung cell suspensions were prepared at various times p.i. A, To identify gB-specific CD8+ T cells in BALF, cells were stained with anti-CD8 Abs and H-2Kb-gB498–505 tetramer. Representative dot plot is shown of the lymphocyte subset at day 7 p.i. B, The percentage of gB-specific CD8+ T cells. Data represent the mean + SD of the percentage of CD8+ lung lymphocytes specific for gB498–505. C, Intracellular production of IFN-{gamma} by CD8+ T cells. Lung cells were stimulated with gB498–505 for 6 h in the presence of brefeldin A before staining for CD8 and intracellular IFN-{gamma}. The mean number ± SD of IFN-{gamma}+ CD8+ T lymphocytes per mouse (from groups of three or four mice) is indicated. Less than 5% of CD8+ BALF cells produced IFN-{gamma} when simulated with an irrelevant peptide (OVA257–264) at any time point tested. D, Specific lysis of gB498–505-coated EL4 target cells was assessed in a standard 51Cr release assay. Data represent the mean percentage + SD of lysis from three or four mice at a lung cell to target cell ratio of 50:1. EL4 targets coated with an equivalent concentration of control peptide (OVA257–264) showed <10% lysis at any time point tested (data not shown). Data are representative of two or more independent experiments.

 
Impaired NK cell function in the lungs of B6.IL-18–/– mice infected with HSV-1

IL-12 and IL-18 also play key roles in innate host defense by enhancing NK cell function, including cytotoxicity and the production of IFN-{gamma}. Original studies by Takeda et al. (28) described defective NK cell activity in B6.IL-18–/– mice; however, subsequent studies have indicated that IL-18 is not always required for NK cell activation during viral infections (31, 32). Thus, it was important to determine whether NK cell function was compromised in B6.IL-18–/–-infected mice following intranasal infection with HSV-1. We first compared lung cell suspensions for their ability to lyse NK-sensitive YAC-1 targets (Fig. 6A). HSV-1-infected B6 and B6.IL-12–/– mice displayed similar profiles of NK cell cytotoxicity and, which was higher than profiles observed in HSV-1-infected B6.IL-18–/– mice on days 1 and 3 p.i., consistent with a defect in NK cell effector function in the absence of IL-18. The number of NK cells present in the lungs of mice 3 days p.i. was determined by flow cytometry and used to calculate NK cell to target cell ratio (Fig. 6B). Although higher numbers of lung NK cells were recovered from infected B6.IL-18–/– mice, the cytotoxic activity on a per cell basis was particularly weak compared with that of B6 mice.


Figure 6
View larger version (39K):
[in this window]
[in a new window]

  		FIGURE 6. Lung NK cells from B6.IL-18–/– mice mediate poor cytotoxic activity. B6, B6.IL-12–/–, or B6.IL-18–/– mice were infected via the intranasal route with 106 PFU of HSV-1. At various times after infection, mice were sacrificed and single-cell suspensions prepared from lung tissues. Specific lysis of NK-sensitive targets by lung cell suspensions was assessed by 51Cr release assay. A, Time course of cytotoxic activity in lung cells from B6 ({blacksquare}), B6.IL-12–/– ({square}), or B6.IL-18–/– (Figure 6) mice against YAC-1 targets. Data are expressed as the mean percentage ± SD of lysis at a total lung cell to target cell ratio of 50:1 (n = 3–4 mice/group) *, p < 0.05, by Student’s t test comparing B6 to B6.IL-18–/– mice. B, Titration of NK cell cytotoxic activity in lung cells from B6 ({blacksquare}), B6.IL-12–/– ({triangleup}), or B6.IL-18–/– (•) mice infected 3 days previously with HSV-1 against YAC-1 cell targets. NK1.1+ CD3– cells were identified by flow cytometry and used to express cytotoxicity results as a lung NK cell to target ratio. C, Cytotoxic activity of lung cells prepared 3 days after intranasal infection of B6 ({blacksquare}), B6.IL-12–/– ({triangleup}), or B6.IL-18–/– (•) with 106 PFU of HSV-1 against RMA-S and RMA-S-Rae1β target cells. D, Expression of intracellular granzyme B by BALF NK cells from B6 (open histogram), B6.IL-12–/– (filled histogram), or B6.IL-18–/– mice (gray-filled histogram) 3 days after intranasal infection with 106 PFU of HSV-1. Data are representative of two or more independent experiments. Mean fluorescence intensity (MFI) values for BALF NK cell granzyme B staining from B6, B6.IL-12–/–, and B6.IL-18–/– mice at day 3 p.i. were 772, 692, and 343 in one experiment and 405, 421, and 146 in an independent experiment.

 
To investigate mechanisms underlying the poor cytotoxic capacity of NK cells from B6.IL-18–/– mice, we tested cytotoxic activity against RMA-S cells and RMA-S cells transfected with Rae1β (RMA-S-Rae1β), a ligand for the activating receptor NKG2D. Lung cells from B6.IL-18–/– mice lysed RMA-S and RMA-S-Rae1β targets poorly compared with lung cells from B6 or B6.IL-12–/– mice (Fig. 6C). Compared with RMA-S targets, lung cells from each of the three mouse strains showed enhanced cytotoxic activity against RMA-S-Rae1β target cells, indicating that the pathway for NKG2D-mediated killing by NK cells remained intact in IL-18-deficient mice. Flow cytometry confirmed that the level of NKG2D expression, as well as CD69, KLRG1, CD25, CD44, CD62L was similar on NK cells recovered from the lungs of HSV-1-infected B6, B6.IL-12–/–, and B6.IL-18–/– mice (data not shown). We did, however, observe a marked decrease in expression of the cytolytic effector molecule granzyme B by BALF NK cells from HSV-1-infected B6.IL-18–/– mice (Fig. 6D), consistent with the poor cytotoxic activity observed ex vivo. Real-time PCR analysis of perforin expression by NK cells (purified by cell sorting from the BALF of HSV-1-infected B6, B6.IL-12–/– and B6.IL-18–/– mice) showed no differences in two independent experiments (data not shown).

We compared BALF NK cells for their ability to produce intracellular IFN-{gamma} directly ex vivo following intranasal HSV-1 infection (Fig. 7A). IFN-{gamma}+ NK cells were detected by day 1, peaked at day 3 and declined at days 5 and 7 (Fig. 7B). Although the total number of BALF NK cells was higher in B6.IL-18–/– mice (Fig. 4B), both proportion and overall number staining for IFN-{gamma} was greatly reduced. The mean fluorescence intensity of IFN-{gamma}+ NK cells was also low in B6.IL-18–/– mice compared with both B6 and B6.IL-12–/– mice (Fig. 7C).


Figure 7
View larger version (38K):
[in this window]
[in a new window]

  		FIGURE 7. BALF NK cells from B6.IL-18–/– mice are poor producers of IFN-{gamma} after intranasal infection. Mice were infected with 106 PFU of HSV-1, and at specific time points p.i. BALF cells were incubated for 4 h with brefeldin A to retain cytokines in their cytoplasm. Cells were stained with FITC-labeled anti-NK1.1, allophycocyanin-labeled anti-CD3, and after permeabilization using saponin with PE-labeled anti-IFN-{gamma} before analysis by three-color flow cytometry. A, Representative dot plots of NK1.1+ CD3– cells recovered 1 day after infection of B6, B6.IL-12–/– or B6.IL-18–/– mice and stained for intracellular expression of IFN-{gamma}. Values shown represent the percentage of NK cells producing intracellular IFN-{gamma}. B, The number of IFN-{gamma}+ NK cells in BALF. C, Mean fluorescence intensity (MFI) of IFN-{gamma} PE expression by IFN-{gamma}+ NK cells in BALF at various times after intranasal HSV-1 infection of B6 ({blacksquare}), B6.IL-12–/– ({triangleup}), or B6.IL-18–/– mice (•). Data shown are from pools of three to five mice and are representative of three experiments. D, IFN-{gamma} levels in cell-free BALF of HSV-1-infected B6 ({blacksquare}), B6.IL-12–/– ({square}), or B6.IL-18–/– mice (Figure 7). Data shown are the mean ± SD from groups of four to five mice. The dashed line indicates 100 pg/ml IFN-{gamma} protein; samples below the dashed line are regarded as < 100 pg/ml.

 
ELISA was used to determine levels of IFN-{gamma} protein in cell-free BALF at days 1, 3, 5, and 7 after HSV-1 infection. Low levels of IFN-{gamma} were detected at days 1 and 3 after infection; however, a striking peak was noted at day 5 and a subsequent decline by day 7 (Fig. 7D). Consistent with a role for NK cells as major producers of early IFN-{gamma}, BALF IFN-{gamma} from B6.IL-18–/– mice was below detection at days 1 and 3 p.i. Of interest, IFN-{gamma} levels were similar in days 5 and 7 BALF from all infected mice, suggesting that other cell types, presumably T cells, produce this cytokine to similar levels in all three mouse strains. Consistent with this notion, depletion of NK cells via treatment of B6 mice with AAGM antisera profoundly reduced BALF IFN-{gamma} levels at days 1 and 3, but had no effect on peak levels at day 5 p.i. (data not shown).

Enhanced replication of HSV-1 is observed in lungs from B6 and B6.IL-12–/– mice, but not from B6.IL-18–/– mice, following depletion of NK cells

To determine the role of NK cells during HSV-1 infection of the respiratory tract we depleted NK cells from B6, B6.IL-12–/– and B6.IL-18–/– mice using antisera-specific for asialo-GM1 (AAGM) before intranasal infection with 106 PFU of HSV-1. Use of AAGM to deplete NK cells can be complicated as activated T cells express "NK cell" markers such as asialo-GM1 and NK1.1 (11). We therefore examined the effects of AAGM treatment at day 3 p.i. as 1) T cell influx into the lung is minimal at day 3 p.i. as assessed by flow cytometry (Figs. 4 and 5) and by in vivo CTL analysis (7), and 2) treatment of mice with anti-CD4 and anti-CD8 Abs has no effect on HSV-1 titers in the lung at this time, despite >90–95% reductions in resident lung T cells (data not shown).

NK cell (NK1.1+, CD3–) depletion of >90% in BALF was confirmed at day 3 p.i. using flow cytometry, with no significant depletion of neutrophils (GR1high, CD11b+), T cells (CD3+, NK1.1–), or macrophages (confirmed by cytospin analysis and differential staining) at this time. Confirming our previous findings (7), NK cell depletion led to a marked exacerbation of viral titers in the lungs of B6 mice at day 3 p.i. (Fig. 8). Viral titers were also enhanced following NK cell depletion of B6.IL-12–/– mice. Of interest, AAGM treatment had only modest effects upon viral titers in the lungs of infected B6.IL-18–/– mice, and viral titers were not significantly different to control B6.IL-18–/– mice (treated with normal rabbit sera) in two independent experiments (p > 0.05, Student’s t test). Together, these data confirm the original findings of Takeda et al. (28) that NK cell function is markedly reduced in B6.IL-18–/– mice (Figs. 6 and 7). Furthermore, they demonstrate a major role for NK cells in early control of HSV-1 replication in the lung as the major impairments in NK cell function observed in B6.IL-18–/– mice were associated with enhanced HSV-1 replication and exacerbation of disease.


Figure 8
View larger version (19K):
[in this window]
[in a new window]

  		FIGURE 8. NK cell depletion does not affect growth of HSV-1 in the lungs of B6.IL-18–/– mice 3 days after intranasal infection with 106 PFU of HSV-1. B6, B6.IL-12–/–, or B6.IL-18–/– mice were treated with AAGM ({square}), normal rabbit sera (NRS) (Figure 8), or PBS ({blacksquare}) and infected with 106 PFU of HSV-1. Titers of infectious virus in lung homogenates were determined at day 3 p.i. by plaque assay on Vero cell monolayers. Data represent mean titers ± SD from groups of four mice. *, p < 0.01 determined by Student’s t test to represent viral titers from AAGM-treated mice that were significantly different to those of PBS-treated or normal rabbit sera-treated controls. Data are representative of three independent experiments.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
NK cells and T cells are components of innate and adaptive responses, respectively, and are recruited to the airways following intranasal HSV-1 infection. The present study shows that a deficiency in IL-18, but not IL-12p40, has profound effects upon the activation status of NK cells in the respiratory tract during HSV-1 infection. In contrast, no functional differences were detected in T cell responses between B6, B6.IL-12–/–, or B6.IL-18–/– mice infected with HSV-1. IL-18 deficiency was associated with exacerbated disease and increased HSV-1 replication in the lung. Depletion of NK cells in B6 and B6.IL-12–/– mice led to increased viral replication in the lung, but had only negligible effects on viral growth in B6.IL-18–/– mice. Collectively, our findings are consistent with a major role for IL-18, but not IL-12, in coordinating rapid NK cell activation in the lung thereby playing a critical role in early control of acute HSV-1 infection.

IL-12 and IL-18 can profoundly influence T cell immunity, acting to enhance proliferation, differentiation and development of T cell effector functions. In addition to promoting the development of Ag-specific T cell immunity, IL-12 and IL-18 can also promote non-Ag-specific IFN-{gamma} production by CD8+ T cells by microbial products (33), early CD8+ T cell responses in murine CMV-infected mice before maximal T cell expansion (34) and turnover of CD8+ memory T cells (35). T cells, in particular CD8+ T cells, were the predominant inflammatory cells recovered from the lung following HSV-1 infection, yet no appreciable defect was observed in the recruitment of CD4+ or CD8+ T cells (Fig. 4D), nor in the function of virus-specific CD8+ T cells (Fig. 5). Furthermore, at times longer than 4 wk p.i. no differences were noted in 1) the effector memory CD8+ T cell population, 2) the quantity and isotype profile of HSV-1 specific Abs in sera or BALF, from B6, B6.IL-12–/–, or B6.IL-18–/– mice (data not shown). Our previous findings describing the clearance of HSV-1 from the lungs of B6.RAG1–/– mice or mice depleted of CD8+ and/or CD4+ cells (7) suggest that innate mechanisms are sufficient to control and clear HSV-1 at the primary site of infection. The expansion and differentiation of T cells may represent a "safeguard" to ensure effective viral clearance and to prevent/limit the reactivation of latent virus in the nerves. Clearly, the absence of either IL-12 or IL-18 does not lead to any gross defects in the development, magnitude or quality of HSV-1-specific immunity in the intranasal model.

Major differences were, however, noted in the quality of NK cell responses in the lungs of IL-18-deficient mice after HSV-1 infection. NK cells were the predominant cell type recovered from BALF early (<day 5) after infection, consistent with an important role in control of early viral replication. Although impairment of NK cell recruitment and cytotoxicity has been reported in lungs from IL-12-deficient mice infected with respiratory syncitial virus (36), we found no such differences during respiratory infection with HSV-1 (Figs. 4, 6, and 7). Increased numbers of pulmonary NK cells were, however, consistently observed in B6.IL-18–/– mice at day 3 p.i. (Fig. 4), but both cytotoxic function (Fig. 6) and IFN-{gamma} production (Fig. 7) were severely compromised. Levels of the cytotoxic effector molecule gramzyme B were reduced in NK cells from B6.IL-18–/– mice (Fig. 6D), offering a possible explanation as to the weak cytotoxic activity of these cells ex vivo. Down-regulation of granzyme B has been associated with the poor cytotoxicity of NK cells observed in murine models of hyperthermia and psychological stress (37, 38). The importance of NK cells in limiting HSV-1 replication in the respiratory tract has been previously reported (7). The current report extends these findings to define a critical role for IL-18 in regulating the activation of NK cells and hence the early control of HSV-1 replication in the lung.

Both IL-12 and IL-18 are capable of augmenting NK cell activation in a number of infectious models. Studies with murine CMV infections have demonstrated that local cytokine requirements for IFN-{gamma} production by NK cells can vary from site to site (for example, IL-18 is required to augment IFN-{gamma} responses in the spleen but not the liver) and that cytokines controlling NK cell IFN-{gamma} production are not necessarily the same as those required for induction of cytotoxic activity (where neither IL-12 nor IL-18 was required for NK cell cytotoxic activity in liver or spleen) (31). In the intranasal model, IL-18 plays the major role in regulating both cytotoxicity and IFN-{gamma} production during HSV-1 infection, whereas IL-12 is largely dispensable. Given that IL-12.p40 mice are also deficient in IL-23 (formed by p40 and p19 heterodimers), an additional cytokine capable of modulating NK and T cell function, it is also clear that IL-23 does not play a major protective role in the respiratory tract following HSV-1 infection. Of interest, IL-12 has been implicated in resistance (39) and corneal scarring (40) following ocular infection of mice with HSV-1. Similarly treatment with recombinant IL-12 was also shown to protect thermally injured mice from HSV-1 infection (41). HSV-1 infection has been reported to induce up-regulation of IL-23 mRNA in TG (42) and prominent IL-12 responses in the eye (43) following corneal infection. A number of reports confirm IL-12 production in the respiratory tract following infection with viruses such as murine gammaherpesvirus 68 and influenza virus (44, 45). In this study we report that despite early induction of IL-12 in respiratory fluids recovered from HSV-1-infected mice (Fig. 3), deficiency in this cytokine had no obvious effect on the course of HSV-1-induced disease following intranasal infection. Together, these studies indicate that the contribution of IL-12 (and/or IL-23) to innate resistance during HSV-1 infection can be very different in distinct anatomical sites.

IL-18 is a multipotent cytokine, initially identified through its ability to enhance IFN-{gamma} responses from NK cells and T cells (46). Recent evidence suggests IL-18 has a much broader range of biological activities such as stimulating the production of other inflammatory cytokines and chemokines (28, 47, 48), enhancing expression of Fas-ligand and adhesion molecules (49, 50) and modulation of neutrophil responses (51, 52) through IFN-{gamma}-independent pathways. Neutrophil recruitment to the airways of B6.IL-18–/– mice was enhanced at days 1 and 3 p.i. (data not shown), however they still represented a very low proportion (<10%) of BALF cells and are likely recruited as a result of the increased viral burden present in the lungs of B6.IL-18–/– mice at these times. As neutrophils are the predominate cell-type infiltrating lesions early after ocular or skin infections with HSV-1 (53, 54), the effects of IL-18 deficiency on neutrophil responses might be better explored in these models.

Fujioka et al. (55) have demonstrated that IL-18 treatment promoted innate immunity to protect mice from i.p. challenge with HSV-1; this mechanism did not appear to require NK cells or NO, leading the authors to speculate on a role for IFN-{gamma} produced before the HSV-1 infection in promoting IL-18-mediated protection. Clearly, in the intranasal model IL-18 is required for efficient NK cell activation (Figs. 6 and 7) and NK cells play a critical role in the early control of HSV-1 replication in the lung (Fig. 8). Local IFN-{gamma} production in the lung appears to be a feature of NK cells early after HSV-1 infection, as IFN-{gamma} levels were below detection in AAGM-treated mice (which we confirmed had been depleted of BALF NK cells but not BALF T cells or macrophages). Together, these studies demonstrate that IL-18 may modulate the innate response to HSV-1 in different ways depending on the site of infection. Our findings highlight a dominant role for IL-18 in coordinating NK cell responses, and therefore early host defense, to HSV-1 infection of the lung.


   Acknowledgment
 
We thank Prof. Francis Carbone for helpful advice and discussion.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by a Program Grant from The National Health and Medical Research Council of Australia. P.C.R. is a National Health and Medical Research Council R. D. Wright Fellow. Back

2 Address correspondence and reprint requests to Dr. Patrick C. Reading, Department of Microbiology and Immunology, University of Melbourne, Melbourne, 3010 Victoria, Australia. E-mail address: preading{at}unimelb.edu.au Back

3 Abbreviations used in this paper: HSV-1, HSV type 1; AAGM, anti-asialo-GM1; TG, trigeminal ganglion; BALF, bronchoalveolar lavage fluid; p.i., postinfection; gB, glycoprotein B. Back

Received for publication June 28, 2007. Accepted for publication June 28, 2007.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Biron, C. A., K. S. Byron, J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735. [Medline]
  2. Dalloul, A., E. Oksenhendler, O. Chosidow, P. Ribaud, G. Carcelain, S. Louvet, P. Massip, P. Lebon, B. Autran. 2004. Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood. J. Clin. Virol. 30: 329-336. [Medline]
  3. Ghiasi, H., S. Cai, G. C. Perng, A. B. Nesburn, S. L. Wechsler. 2000. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antiviral Res. 45: 33-45. [Medline]
  4. Habu, S., K. Akamatsu, N. Tamaoki, K. Okumura. 1984. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice. J. Immunol. 133: 2743-2747. [Abstract]
  5. Pereira, R. A., A. Scalzo, A. Simmons. 2001. Cutting edge: a NK complex-linked locus governs acute versus latent herpes simplex virus infection of neurons. J. Immunol. 166: 5869-5873. [Abstract/Free Full Text]
  6. Rager-Zisman, B., P. C. Quan, M. Rosner, J. R. Moller, B. R. Bloom. 1987. Role of NK cells in protection of mice against herpes simplex virus-1 infection. J. Immunol. 138: 884-888. [Abstract]
  7. Reading, P. C., P. G. Whitney, D. P. Barr, M. J. Smyth, A. G. Brooks. 2006. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection. Eur. J. Immunol. 36: 897-905. [Medline]
  8. Bukowski, J. F., R. M. Welsh. 1986. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J. Immunol. 136: 3481-3485. [Abstract]
  9. Engler, H., R. Zawatzky, A. Goldbach, C. H. Schroder, C. Weyand, G. J. Hammerling, H. Kirchner. 1981. Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in the peritoneal exudate. J. Gen. Virol. 55: 25-30. [Abstract/Free Full Text]
  10. Wu, L., P. S. Morahan. 1992. Macrophages and other nonspecific defenses: role in modulating resistance against herpes simplex virus. Curr. Top. Microbiol. Immunol. 179: 89-110. [Medline]
  11. Slifka, M. K., R. R. Pagarigan, J. L. Whitton. 2000. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J. Immunol. 164: 2009-2015. [Abstract/Free Full Text]
  12. Manickan, E., B. T. Rouse. 1995. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models. J. Virol. 69: 8178-8179. [Abstract]
  13. Manickan, E., R. J. Rouse, Z. Yu, W. S. Wire, B. T. Rouse. 1995. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J. Immunol. 155: 259-265. [Abstract]
  14. Simmons, A., D. C. Tscharke. 1992. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175: 1337-1344. [Abstract/Free Full Text]
  15. van Lint, A., M. Ayers, A. G. Brooks, R. M. Coles, W. R. Heath, F. R. Carbone. 2004. Herpes simplex virus-specific CD8+ T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J. Immunol. 172: 392-397. [Abstract/Free Full Text]
  16. Kohno, K., J. Kataoka, T. Ohtsuki, Y. Suemoto, I. Okamoto, M. Usui, M. Ikeda, M. Kurimoto. 1997. IFN-{gamma}-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158: 1541-1550. [Abstract]
  17. Okamura, H., H. Tsutsi, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, et al 1995. Cloning of a new cytokine that induces IFN-{gamma} production by T cells. Nature 378: 88-91. [Medline]
  18. Ahn, H. J., S. Maruo, M. Tomura, J. Mu, T. Hamaoka, K. Nakanishi, S. Clark, M. Kurimoto, H. Okamura, H. Fujiwara. 1997. A mechanism underlying synergy between IL-12 and IFN-{gamma}-inducing factor in enhanced production of IFN-{gamma}. J. Immunol. 159: 2125-2131. [Abstract/Free Full Text]
  19. Yoshimoto, T., H. Okamura, Y. I. Tagawa, Y. Iwakura, K. Nakanishi. 1997. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-{gamma} production from activated B cells. Proc. Natl. Acad. Sci. USA 94: 3948-3953. [Abstract/Free Full Text]
  20. Zhang, T., K. Kawakami, M. H. Qureshi, H. Okamura, M. Kurimoto, A. Saito. 1997. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of {gamma} interferon by natural killer cells. Infect. Immun. 65: 3594-3599. [Abstract]
  21. Trinchieri, G.. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146. [Medline]
  22. Holscher, C.. 2004. The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med. Microbiol. Immunol. 193: 1-17. [Medline]
  23. Gu, Y., K. Kuida, H. Tsutsui, G. Ku, K. Hsiao, M. A. Fleming, N. Hayashi, K. Higashino, H. Okamura, K. Nakanishi, et al 1997. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275: 206-209. [Abstract/Free Full Text]
  24. Hull, H. F., J. D. Blumhagen, D. Benjamin, L. Corey. 1984. Herpes simplex viral pneumonitis in childhood. J. Pediatr. 104: 211-215. [Medline]
  25. Smyth, R. L., T. W. Higenbottam, J. P. Scott, T. G. Wreghitt, S. Stewart, C. A. Clelland, J. P. McGoldrick, J. Wallwork. 1990. Herpes simplex virus infection in heart-lung transplant recipients. Transplantation 49: 735-739. [Medline]
  26. Whitley, R. J.. 1990. Viral encephalitis. N. Engl. J. Med. 323: 242-250. [Medline]
  27. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, M. K. Gately. 1996. IL-12-deficient mice are defective in IFN {gamma} production and type 1 cytokine responses. Immunity 4: 471-481. [Medline]
  28. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8: 383-390. [Medline]
  29. Jones, C. M., S. C. Cose, R. M. Coles, A. C. Winterhalter, A. G. Brooks, W. R. Heath, F. R. Carbone. 2000. Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection. J. Virol. 74: 2414-2419. [Abstract/Free Full Text]
  30. Hayakawa, Y., J. M. Kelly, J. A. Westwood, P. K. Darcy, A. Diefenbach, D. Raulet, M. J. Smyth. 2002. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. J. Immunol. 169: 5377-5381. [Abstract/Free Full Text]
  31. Pien, G. C., A. R. Satoskar, K. Takeda, S. Akira, C. A. Biron. 2000. Cutting edge: selective IL-18 requirements for induction of compartmental IFN-{gamma} responses during viral infection. J. Immunol. 165: 4787-4791. [Abstract/Free Full Text]
  32. Van Der Sluijs, K. F., L. J. Van Elden, R. Arens, M. Nijhuis, R. Schuurman, S. Florquin, J. Kwakkel, S. Akira, H. M. Jansen, R. Lutter, T. Van Der Polls. 2005. Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus. Immunology 114: 112-120. [Medline]
  33. Raue, H. P., J. D. Brien, E. Hammarlund, M. K. Slifka. 2004. Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18. J. Immunol. 173: 6873-6881. [Abstract/Free Full Text]
  34. Pien, G. C., K. B. Nguyen, L. Malmgaard, A. R. Satoskar, C. A. Biron. 2002. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J. Immunol. 169: 5827-5837. [Abstract/Free Full Text]
  35. Tough, D. F., X. Zhang, J. Sprent. 2001. An IFN-{gamma}-dependent pathway controls stimulation of memory phenotype CD8+ T cell turnover in vivo by IL-12, IL-18, and IFN-{gamma}. J. Immunol. 166: 6007-6011. [Abstract/Free Full Text]
  36. Ehl, S., R. Bischoff, T. Ostler, S. Vallbracht, J. Schulte-Monting, A. Poltorak, M. Freudenberg. 2004. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur. J. Immunol. 34: 1146-1153. [Medline]
  37. Koga, T., H. Harada, T. S. Shi, S. Okada, M. A. Suico, T. Shuto, H. Kai. 2005. Hyperthermia suppresses the cytotoxicity of NK cells via down-regulation of perforin/granzyme B expression. Biochem. Biophys. Res. Commun. 337: 1319-1323. [Medline]
  38. Li, Q., Z. Liang, A. Nakadai, T. Kawada. 2005. Effect of electric foot shock and psychological stress on activities of murine splenic natural killer and lymphokine-activated killer cells, cytotoxic T lymphocytes, natural killer receptors and mRNA transcripts for granzymes and perforin. Stress 8: 107-116. [Medline]
  39. Al-Khatib, K., I. L. Campbell, D. J. Carr. 2002. Resistance to ocular herpes simplex virus type 1 infection in IL-12 transgenic mice. J. Neuroimmunol. 132: 41-48. [Medline]
  40. Osorio, Y., S. L. Wechsler, A. B. Nesburn, H. Ghiasi. 2002. Reduced severity of HSV-1-induced corneal scarring in IL-12-deficient mice. Virus Res. 90: 317-326. [Medline]
  41. Matsuo, R., M. Kobayashi, D. N. Herndon, R. B. Pollard, F. Suzuki. 1996. Interleukin-12 protects thermally injured mice from herpes simplex virus type 1 infection. J. Leukocyte Biol. 59: 623-630. [Abstract]
  42. Broberg, E. K., N. Setala, J. P. Eralinna, A. A. Salmi, M. Roytta, V. Hukkanen. 2002. Herpes simplex virus type 1 infection induces upregulation of interleukin-23 (p19) mRNA expression in trigeminal ganglia of BALB/c mice. J. Interferon Cytokine. Res. 22: 641-651. [Medline]
  43. Kanangat, S., J. Thomas, S. Gangappa, J. S. Babu, B. T. Rouse. 1996. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression: implications in immunopathogenesis and protection. J. Immunol. 156: 1110-1116. [Abstract]
  44. Elsawa, S. F., K. L. Bost. 2004. Murine gamma-herpesvirus-68-induced IL-12 contributes to the control of latent viral burden, but also contributes to viral-mediated leukocytosis. J. Immunol. 172: 516-524. [Abstract/Free Full Text]
  45. Monteiro, J. M., C. Harvey, G. Trinchieri. 1998. Role of interleukin-12 in primary influenza virus infection. J. Virol. 72: 4825-4831. [Abstract/Free Full Text]
  46. Fantuzzi, G., C. A. Dinarello. 1999. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J. Clin. Immunol. 19: 1-11. [Medline]
  47. Netea, M. G., B. J. Kullberg, I. Verschueren, J. W. Van Der Meer. 2000. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1β. Eur. J. Immunol. 30: 3057-3060. [Medline]
  48. Puren, A. J., G. Fantuzzi, Y. Gu, M. S. Su, C. A. Dinarello. 1998. Interleukin-18 (IFN{gamma}-inducing factor) induces IL-8 and IL-1β via TNF{alpha} production from non-CD14+ human blood mononuclear cells. J. Clin. Invest. 101: 711-721. [Medline]
  49. Kohka, H., T. Yoshino, H. Iwagaki, I. Sakuma, T. Tanimoto, Y. Matsuo, M. Kurimoto, K. Orita, T. Akagi, N. Tanaka. 1998. Interleukin-18/interferon-{gamma}-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J. Leukocyte. Biol. 64: 519-527. [Abstract]
  50. Tsutsui, H., K. Nakanishi, K. Matsui, K. Higashino, H. Okamura, Y. Miyazawa, K. Kaneda. 1996. IFN-{gamma}-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157: 3967-3973. [Abstract]
  51. Leung, B. P., S. Culshaw, J. A. Gracie, D. Hunter, C. A. Canetti, C. Campbell, F. Cunha, F. Y. Liew, I. B. McInnes. 2001. A role for IL-18 in neutrophil activation. J. Immunol. 167: 2879-2886. [Abstract/Free Full Text]
  52. Netea, M. G., G. Fantuzzi, B. J. Kullberg, R. J. Stuyt, E. J. Pulido, R. C. McIntyre, Jr, L. A. Joosten, J. W. Van der Meer, C. A. Dinarello. 2000. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J. Immunol. 164: 2644-2649. [Abstract/Free Full Text]
  53. Stumpf, T. H., R. Case, C. Shimeld, D. L. Easty, T. J. Hill. 2002. Primary herpes simplex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids. J. Gen. Virol. 83: 1579-1590. [Abstract/Free Full Text]
  54. Watanabe, D., A. Adachi, Y. Tomita, M. Yamamoto, M. Kobayashi, Y. Nishiyama. 1999. The role of polymorphonuclear leukocyte infiltration in herpes simplex virus infection of murine skin. Arch Dermatol. Res. 291: 28-36. [Medline]
  55. Fujioka, N., R. Akazawa, K. Ohashi, M. Fujii, M. Ikeda, M. Kurimoto. 1999. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J. Virol. 73: 2401-2409. [Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
Y. Wang, G. Chaudhri, R. J. Jackson, and G. Karupiah
IL-12p40 and IL-18 Play Pivotal Roles in Orchestrating the Cell-Mediated Immune Response to a Poxvirus Infection
J. Immunol., September 1, 2009; 183(5): 3324 - 3331.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. J. Park, M. A. Hughes, M. Burdick, R. M. Strieter, and B. Mehrad
Early NK Cell-Derived IFN-{gamma} Is Essential to Host Defense in Neutropenic Invasive Aspergillosis
J. Immunol., April 1, 2009; 182(7): 4306 - 4312.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reading, P. C.
Right arrow Articles by Brooks, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reading, P. C.
Right arrow Articles by Brooks, A. G.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS